CIRS Group is to attend the Boao Health Food Science Conference & Expo (FHE) on 22-25 February 2023 in Hainan Province, China and will set a booth (Booth No.: C23) during the expo.

On January 19, 2023, China National Center for Food Safety Risk Assessment (CFSA) released National Food Safety Standard - Standard for the Use of Food Nutrition Enhancers (Draft) for public comment. Significant changes have been made and we have summarized them as follows:

On February 10, 2023, China National Center for Food Safety Risk Assessment (CFSA) issued five food additives for public comment. This included two new food enzymes, one new food nutrition enhancer, one food additive with expanded scope, and one food nutrition enhancers with expanded scope and dosage. The deadline for public comments is March 8, 2023.

On November 30, 2022, the European Commission issued Regulation (EU) 2022/2340 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council, which included green tea extracts containing (-)- epigallocatechin-3-gallate (EGCG) in restricted substance list. The Regulation has been in force since December 21, 2022, and food items that include green tea extracts containing EGCG, which do not comply with the requirements of this Regulation and were lawfully placed on the market before the entry into force of this Regulation will no longer be allowed to be on the market from June 21, 2023.

As of December 31, 2022, China's State Administration for Market Regulation (SAMR) has issued a total of 1,445 health food and dietary supplement registration approvals, 421 of which were new health food products. We have conducted a detailed summary of these 421 new products and analyzed them from the following points.

On January 16, 2023, CIRS Group announced the opening of a new office in Shanghai, as it continues its expansion into the global market. Located in the heart of Pudong – Shanghai's central business district – the Shanghai Office will devote itself to providing timely and sound product compliance services and solutions to clients in Shanghai and the surrounding areas.

According to information recently released by the State Administration for Market Regulation (SAMR), the number of foods for special medical purposes (FSMP) products approved in China has reached 94. Companies must register FSMP products with the SAMR. This applies to both imported products as well as those produced domestically and marketed in China. 13 new FSMP products were approved for use in 2022.

In order to help enterprises better understand the filing status of health food (dietary supplement) in China, CIRS made statistics on the health food approved in 2022 and made an analysis from multiple perspectives.

On January 16, 2023, China National Center for Food Safety Risk Assessment (CFSA) issued 3 new food contact additives and resins passing the technical review of the CFSA Expert Review Committee for public comments. The deadline for public comments is February 10, 2023.

By the end of December 2022, the National Health Commission of the People's Republic of China (NHC) issued three announcements (No. 1 of 2022, No. 2 of 2022, No. 5 of 2022) in the form of "Three New Foods" with 75 of products approved, including new food raw materials (novel food), new food additives and food-related products (new food contact substances). Among them, 32 kinds of new food additives (including expanded use) were approved.